Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GMA-M52H3 | Mouse | Mouse GM-CSF R alpha Protein, His Tag |  |
|
|
| GRA-H5255 | Human | Human GM-CSF R alpha Protein, Fc Tag |  |
|
|
| GRA-H52H7 | Human | Human GM-CSF R alpha Protein, His Tag (SPR verified) |  |
|
|
Human GM-CSF R alpha, His Tag (Cat. No. GRA-H52H7) captured on CM5 Chip via anti-His antibody, can bind Human GM-CSF, premium grade (Cat. No. GMF-H4214) with an affinity constant of 16.1 nM as determined in SPR assay (Biacore T200) (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Mavrilimumab | CAM-3001; KPL-301; GM-CSFR; CAM3001 | Phase 3 Clinical | Csl Ltd | Pneumonia; Giant Cell Arteritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) | Details |
| Anti-GMR CAR T-cell Therapy | Phase 2 Clinical | Kyoto Prefectural University Of Medicine, Shinshu University School of Medicine | Leukemia, Myelomonocytic, Juvenile; Leukemia, Myeloid, Acute | Details | |
| CSF2RA gene-corrected macrophages(University of South Florida) | Phase 2 Clinical | Russian Academy Of Medical Sciences | Pulmonary Alveolar Proteinosis | Details | |
| STSA-1005 | STSA-1005; STSA1005 | Phase 1 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Coronavirus Disease 2019 (COVID-19) | Details |
This web search service is supported by Google Inc.
A-Z
